Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Watson-Marlow Builds Devens, Massachusetts, U.S. Manufacturing Campus

10/28/2021
Watson-Marlow, a company that specializes in high-quality fluid management solutions for the life sciences and process industries, will build a new 150,000 square foot state-of-the-art manufacturing facility in Devens, Massachusetts. The project is expected to create 150 jobs.

The new facility, which is expected to start production in late 2022 will be dedicated to a range of industry leading products, including peristaltic pumps, tubing, fluid path solutions and BioPure components. The location will strengthen the support the Company provides to customers in the region across its core sectors of pharmaceutical and biotechnology, medical diagnostics, and process industries., company officials noted.

"The new U.S. facility is an important milestone in the Watson-Marlow company history and marks a significant commitment to serving our customers in the Americas region," said Andrew Mines, Watson-Marlow Managing Director, "This exciting development is bringing us closer to our customers whose purpose is to help the world around us, from advancing cell and gene therapies through to ensuring people have access to clean drinking water.”

Part of British-based Spirax-Sarco Engineering, a FTSE100 Company, Watson-Marlow has been making some of the most innovative fluid management solutions in the world since 1956.

“ Together we will continue to develop market-leading fluid management solutions to engineer a more sustainable future. A huge thanks goes to the Watson-Marlow, BioPure, Americas and Watson-Marlow Central Support teams that are making this happen, as well as to our parent Company, Spirax-Sarco Engineering who have enabled us to make such a significant investment in our future,” Mines added.

Exclusive Research